Navigation Links
Otonomy Introduces Scientific Advisory Board
Date:3/30/2009

the ear for diagnostic purposes and the 3D anatomy of the inner ear. He was a clinical physiologist at the Institute for Sound and Vibrations Research, University of Southampton, England and did postdoctoral training at the National Institute for Environmental Health Sciences in North Carolina. Dr. Salt received his Ph.D. in cochlear physiology from the University of Birmingham, England, where he also earned his M.S. in neurocommunications. He was the winner of the 2008 Gold Medal Award from the Prosper Meniere Society and the 1999 Guyot Prize from the University of Groningen, The Netherlands, for "important work of great merits in the field of otological and biological research".

About Otonomy

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field represents a large untapped opportunity with nearly 30 million Americans facing debilitating hearing and balance disorders. Currently, no approved drug treatments exist for these conditions. In addition, more than 5 million annual cases of ear infection are still treated with resistance-causing oral antibiotics or locally administered drugs that require surgical perforation of the ear drum. Otonomy is working in partnership with leading experts in the field to bring new drug therapies to these unserved patients. For more information, visit www.otonomy.com.

Editor's Note: Photographs available on request

    Media Contact
    Heidi Chokeir, Ph.D., or David Schull
    Russo Partners
    O (619) 528-2217
    M (858) 380-6584
    heidi.chokeir@russopartnersllc.com
    david.schull@russopartnersllc.com


'/>"/>
SOURCE Otonomy Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
2. PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace
3. DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
4. Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting
5. GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
8. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
9. Max Muscle Introduces First-Ever Probiotics Protein Bar
10. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Sunnyvale, CA (PRWEB) November 25, 2014 ... joins forces with RPM Alliance , provider ... and pharmaceutical companies. With the latest addition to its ... only free validated EDC system to India. , ... as a robust and customizable EDC platform which is ...
(Date:11/26/2014)... 25, 2014 Miles Holder, formerly of ... Graphel Carbon Products team as Sales/Marketing Manager. Mr. Holder ... customer service for the graphite industry. , “We are ... team,” stated Dave Trinkley, VP of Market and Product ... of experience in the graphite industry, along with his ...
(Date:11/26/2014)... 2014 Theravalues Corporation est fier d,annoncer ... européen au salon Hi Europe 2014 (du 2 ... Curcumine la plus biodisponible actuellement sur ... à des ingrédients approuvés par les règlements européens. ... présent dans la racine de curcuma ( Curcuma ...
(Date:11/24/2014)... , Nov. 24, 2014  IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, today announced it has ... the U.S. Food and Drug Administration (FDA), which brings ... to seven, with eighteen submissions now pending at the ... and CEO of the Company, commented, "Our team here ...
Breaking Biology Technology:RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2
... , , , ... ) announced that it will be hosting a conference call to discuss today,s ... begin at 8:30 a.m. Eastern Time (ET)/5:30 a.m. Pacific Time (PT). , ... accessed through a link that is posted on the home page of Nektar,s ...
... ... firms have to follow a rigorous documentation process to comply with a ... corporate agreements these firms are faced with the daunting task of sharing ... affordable unlimited use facility to share thousands of confidential documents securely and ...
... question, researchers with the U.S. Department of Energy,s ... that the selective placement of strain can alter ... correlated electron materials. This unique class of materials ... display properties such as colossal magnetoresistance and high-temperature ...
Cached Biology Technology:Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 2Life Science Firms are Turning to Firmex to do Deals Online 2Life Science Firms are Turning to Firmex to do Deals Online 3Strain on nanocrystals could yield colossal results 2Strain on nanocrystals could yield colossal results 3
(Date:11/4/2014)... , Nov. 4, 2014   Neurotechnology ... today announced that the latest version of its ... the Ongoing MINEX evaluation organized by ... fingerprint algorithms using the INCITS 378 fingerprint standard ... requirement in public tenders in the ...
(Date:11/3/2014)... Center study published in this month,s ... the activity of a recently discovered communication molecule of ... has been known to limit inflammation and the current ... IL-37 inhibits the ability of the immune system to ... that underlies IL-37,s effect on the immune system now ...
(Date:11/3/2014)... from Australia report that low birth weight and preterm ... hip replacements in adulthood. Findings published in the American ... Research , indicate that low birth weight and pre-term ... due to OA as adults. , According to ... 25 are diagnosed with clinical OA. Symptoms of OA ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2
... University of California, Davis have discovered that a prototype ... causes of heart failure. Heart failure, which ... the body, affects 5 million people in the United ... The research in the laboratories of cardiologist ...
... but is dangerous to your eyes and skin, says a ... absolutely no benefit over bleaching without UV, and damages skin ... reports a study in Photochemical & Photobiological Sciences . ... be better off ignoring claims of better bleaching with UV ...
... Texas AgriLife Research scientists, talk about their study which reveal antioxidant and phytonutrient properties in stone fruits, ... Click here for more information. ... , , , , ... , , ...
Cached Biology News:UC Davis research shows that newly discovered drug reduces heart enlargement 2Plums poised to give blueberries run for the money 2Plums poised to give blueberries run for the money 3Plums poised to give blueberries run for the money 4